 |
|
Position Statement: Postmenopausal Osteoporosis Treatment Strategies in Korea
So Young Park, Se Hwa Kim, Young-Kyun Lee, Jung-Ho Shin, Yong-Chan Ha, Ho Yeon Chung
J Bone Metab. 2023;30(4):289-295. Published online 2023 Nov 30 DOI: https://doi.org/10.11005/jbm.2023.30.4.289
|
|
Citations to this article as recorded by
 Effects of denosumab and zoledronic acid on postmenopausal osteoporosis, bone density, and fat-free mass
Jeonghoon Ha, Jinyoung Kim, Chaiho Jeong, Jeongmin Lee, Yejee Lim, Ki-Hyun Baek
Archives of Osteoporosis.2025;[Epub] CrossRef Long-Term Efficacy and Safety of Denosumab: Insights beyond 10 Years of Use
Jeonghoon Ha, Youn-Ju Lee, Jinyoung Kim, Chaiho Jeong, Yejee Lim, Jeongmin Lee, Ki-Hyun Baek
Endocrinology and Metabolism.2025; 40(1): 47. CrossRef Twenty-Year Trends in Osteoporosis Treatment and Post-Fracture Care in South Korea: A Nationwide Study
Kyoung Jin Kim, Kyoung Min Kim, Young-Kyun Lee, Jihye Kim, Hoyeon Jang, Jaiyong Kim, Ha Young Kim
Journal of Bone Metabolism.2025; 32(1): 57. CrossRef The prevention of osteoporotic vertebral fractures in eastern and in western countries
Fjorda Koromani, Jiawei Li, Hiroshi Hagino, Richard Eastell, Annegreet Vlug, Ling Wang, Hua Yue, Yong-Chan Ha, Steven Cummings, Salvatore Minisola, Claus-C. Glüer, Ling Oei
Bone Reports.2025; 25: 101851. CrossRef Epidemiological (secular) trends of pelvic and acetabular fractures (2006–2022) in South Korea using a nationwide cohort data over ages 50: is it osteoporosis related?
Byung-Ho Yoon, Tae-Young Kim, HoeJeong Chung, Jaiyong Kim, Jihye Kim, Hoyeon Jang, Young-Kyun Lee
Archives of Osteoporosis.2025;[Epub] CrossRef Denosumab and the Rebound Effect: Current Aspects of Osteoporosis Therapy (Review)
N. Yu. Velts, O. V. Velts, R. N. Alyautdin
Safety and Risk of Pharmacotherapy.2024; 12(2): 190. CrossRef Denosumab in Osteoporosis: Predicting Long-Term Efficacy beyond 10 Years
Jeongmin Lee, Youn-Ju Lee, Jeonghoon Ha
Journal of Bone Metabolism.2024; 31(3): 246. CrossRef
|